X-48604318-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001347217.2(WDR13):āc.1201A>Gā(p.Ile401Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000397 in 1,209,734 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000045 ( 0 hom., 3 hem., cov: 23)
Exomes š: 0.000039 ( 0 hom. 12 hem. )
Consequence
WDR13
NM_001347217.2 missense
NM_001347217.2 missense
Scores
1
3
12
Clinical Significance
Conservation
PhyloP100: 5.61
Genes affected
WDR13 (HGNC:14352): (WD repeat domain 13) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by Gly-His and Trp-Asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. A similar protein in mouse is thought to be a negative regulator of the pancreatic beta cell proliferation. Mice lacking this gene exhibit increased pancreatic islet mass and higher serum insulin levels, and are mildly obese. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), WDR13. . Gene score misZ 3.2948 (greater than the threshold 3.09). GenCC has associacion of gene with intellectual disability.
BP4
Computational evidence support a benign effect (MetaRNN=0.09067017).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR13 | NM_001347217.2 | c.1201A>G | p.Ile401Val | missense_variant | 9/10 | ENST00000376729.10 | NP_001334146.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR13 | ENST00000376729.10 | c.1201A>G | p.Ile401Val | missense_variant | 9/10 | 5 | NM_001347217.2 | ENSP00000365919 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000446 AC: 5AN: 112131Hom.: 0 Cov.: 23 AF XY: 0.0000875 AC XY: 3AN XY: 34295
GnomAD3 genomes
AF:
AC:
5
AN:
112131
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34295
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000553 AC: 10AN: 180710Hom.: 0 AF XY: 0.0000306 AC XY: 2AN XY: 65318
GnomAD3 exomes
AF:
AC:
10
AN:
180710
Hom.:
AF XY:
AC XY:
2
AN XY:
65318
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000392 AC: 43AN: 1097549Hom.: 0 Cov.: 30 AF XY: 0.0000331 AC XY: 12AN XY: 362921
GnomAD4 exome
AF:
AC:
43
AN:
1097549
Hom.:
Cov.:
30
AF XY:
AC XY:
12
AN XY:
362921
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000446 AC: 5AN: 112185Hom.: 0 Cov.: 23 AF XY: 0.0000873 AC XY: 3AN XY: 34359
GnomAD4 genome
AF:
AC:
5
AN:
112185
Hom.:
Cov.:
23
AF XY:
AC XY:
3
AN XY:
34359
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2023 | The c.1201A>G (p.I401V) alteration is located in exon 8 (coding exon 8) of the WDR13 gene. This alteration results from a A to G substitution at nucleotide position 1201, causing the isoleucine (I) at amino acid position 401 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Vest4
MutPred
Gain of ubiquitination at K396 (P = 0.0913);Gain of ubiquitination at K396 (P = 0.0913);.;
MVP
MPC
0.88
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at